KION GROUP AG (KIGRY)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,926	4,325	5,605	3,751	14,383	11,410
Market Cap Growth	32.46%	-22.83%	49.43%	-73.92%	26.06%	40.11%
Enterprise Value	17,256	11,327	12,593	10,234	19,951	18,200
Last Close Price	17.01	8.04	10.39	6.90	26.29	20.47
PE Ratio	33.04	11.60	16.58	35.81	22.25	43.32
PS Ratio	0.67	0.36	0.44	0.32	1.23	1.12
PB Ratio	1.29	0.67	0.88	0.63	2.45	2.18
P/TBV Ratio	20.63	11.16	49.76	-	-	-
P/FCF Ratio	10.95	5.90	7.23	-	23.08	38.34
P/OCF Ratio	6.63	3.57	4.43	-	14.34	17.70
EV/Sales Ratio	1.31	0.95	1.00	0.86	1.70	1.78
EV/EBITDA Ratio	9.11	6.34	7.48	9.51	11.20	12.43
EV/EBIT Ratio	29.10	14.19	18.42	72.27	23.26	36.94
EV/FCF Ratio	21.18	15.46	16.25	-	32.02	61.15
Debt / Equity Ratio	1.32	1.24	1.15	1.13	1.00	1.16
Debt / EBITDA Ratio	4.80	4.09	3.98	5.53	3.04	3.77
Debt / FCF Ratio	11.16	10.87	9.46	-	9.41	20.41
Asset Turnover	0.62	0.64	0.67	0.69	0.69	0.60
Inventory Turnover	4.40	4.72	4.78	5.24	5.69	5.76
Quick Ratio	0.59	0.67	0.65	0.65	0.58	0.57
Current Ratio	0.97	1.01	1.06	1.05	0.92	0.89
Return on Equity (ROE)	3.98%	6.16%	5.53%	1.96%	12.03%	5.39%
Return on Assets (ROA)	1.71%	2.66%	2.27%	0.51%	3.15%	1.81%
Return on Capital (ROIC)	2.33%	3.66%	3.17%	0.74%	4.82%	2.76%
Return on Capital Employed (ROCE)	3.90%	5.80%	5.00%	1.10%	7.00%	3.90%
Earnings Yield	3.03%	8.62%	6.03%	2.79%	4.49%	2.31%
FCF Yield	9.13%	16.94%	13.83%	-20.76%	4.33%	2.61%
Dividend Yield	0.91%	10.55%	7.45%	2.94%	6.49%	2.45%
Payout Ratio	46.74%	25.48%	8.14%	200.71%	9.45%	2.18%
Buyback Yield / Dilution	-0.01%	-0.01%	-	-	-10.26%	-0.85%
Total Shareholder Return	0.91%	10.55%	7.45%	2.94%	-3.77%	1.60%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.